William J. Febbo - Aug 19, 2022 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
CEO, Director
Signature
/s/ William Febbo
Stock symbol
OPRX
Transactions as of
Aug 19, 2022
Transactions value $
$251,005
Form type
4
Date filed
8/23/2022, 04:45 PM
Previous filing
Aug 8, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Purchase $87.4K +5.4K +1.21% $16.18 451K Aug 19, 2022 Direct F1
transaction OPRX Common Stock Purchase $164K +10.7K +2.37% $15.29 462K Aug 22, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.13 to $16.24. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $15.43. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.